Perelman School of Medicine

Ten scholars representing five schools across the University of Pennsylvania have been named to the 2021 class of American Association for the Advancement of Science Fellows, recognized for their “scientifically and socially distinguished achievements.”

Katherine Unger Baillie ・January 26, 2022

Creating a greener, more equitable future at the site means understanding its complex history, its long-running public health impacts, and working in partnership with communities.

Erica K. Brockmeier ・January 26, 2022

A new Penn study demonstrates that engineered macrophages, which can be targeted to tumors, may be a possible new immune-based treatment of some cancers.

From Penn Medicine News ・January 24, 2022

An inequity in the rate of Black patients making it to their primary care appointment after a hospitalization was eliminated after telemedicine became widely used amid the COVID-19 pandemic.

From Penn Medicine News ・January 21, 2022

Two new studies highlight the problem with aggregating diverse groups of people into a single category of “Asian American” when applied to cardiovascular disease and cancer diagnosis and outcomes.

From Penn LDI ・January 20, 2022

Penn Medicine researchers have developed a new technique that uses complement inhibitor Factor I to prevent proteins from attacking treatment-carrying nanoparticles so they can better reach targets within the body.

Sophie Kluthe ・January 19, 2022

Penn Engineering researchers have described a new type of optogenetic protein that can be controlled not only by light, but also by temperature, allowing for a higher degree of control in the manipulation of cellular pathways.

From Penn Engineering Today ・January 14, 2022

Penn researchers find that using wearable devices, especially those on the wrist, and machine learning approaches could predict blood sugar control.

From Penn Medicine News ・January 13, 2022

Making up for the genetic mutations of MLL4 in skin cells, one of the most commonly mutated genes across all of human cancers, may keep epithelial cancer from beginning and progressing

Alex Gardner ・January 12, 2022

The Perelman School of Medicine’s Frederic Bushman and Susan Weiss share what they and other scientists are learning about the new, dominant variant of SARS-CoV-2.

Katherine Unger Baillie ・January 11, 2022